Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 12, 2014, Pages 2111-2119

  Mamishi, S ^a   Pourakbari, B ^a   Teymuri, M ^a   Rubbo, P A ^b,c,d   Tuaillon, E ^b,c,d   Keshtkar, A A ^e   Mahmoudi, S ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIV MONTPELLIER   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d UMR 1058 University of Montpellier   (France)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 2;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; EMBASE; GOLD STANDARD; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MEDLINE; META ANALYSIS; PUBLISHING; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; WEB OF SCIENCE; AREA UNDER THE CURVE; BLOOD; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC;

AREA UNDER CURVE; BIOLOGICAL MARKERS; HUMANS; IMMUNOLOGIC TESTS; INTERLEUKIN-2; LATENT TUBERCULOSIS; ROC CURVE;

EID: 84919591979     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2190-z     Document Type: Review

References (33)

1. World Health Organization (WHO) (2010) Global tuberculosis control 2010. WHO
2. Centers for Disease Control and Prevention (CDC) (2010) Latent tuberculosis infection: a guide for primary health care providers. CDC, Atlanta
3. Goletti D, Vincenti D, Carrara S, Butera O, Bizzoni F, Bernardini G et al (2005) Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 12:1311–1316
4. Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D et al (2009) Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 9:99
5. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ et al (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357:2017–2021
6. Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146:340–354
7. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P (2004) Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170:65–69
8. Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ et al (2011) Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One 6:e26545
9. Wang S, Diao N, Lu C, Wu J, Gao Y, Chen J et al (2012) Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS One 7:e51338
10. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP et al (2007) Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 178:5217–5226
11. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25
12. Westwood ME, Whiting PF, Kleijnen J (2005) How does study quality affect the results of a diagnostic meta-analysis? BMC Med Res Methodol 5:20
13. Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data‐analytic approaches and some additional considerations. Stat Med 12:1293–1316
14. Lijmer JG, Bossuyt PM, Heisterkamp SH (2002) Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 21:1525–1537
15. Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20:2865–2884
16. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893
17. Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, Cadogan E et al (2011) Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 91:250–256
18. Rubbo PA, Nagot N, Le Moing V, Brabet M, Bourdin A, Nogué E et al (2012) Multicytokine detection improves latent tuberculosis diagnosis in health care workers. J Clin Microbiol 50:1711–1717
19. Kim SY, Park MS, Kim YS, Kim SK, Chang J, Lee HJ et al (2012) The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7. Scand J Immunol 76:580–586
20. Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F et al (2010) Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect 16:1282–1284
21. Lighter-Fisher J, Peng CH, Tse DB (2010) Cytokine responses to QuantiFERON® peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis. Int J Tuberc Lung Dis 14:1548–1555
22. Chiappini E, Della Bella C, Bonsignori F, Sollai S, Amedei A, Galli L et al (2012) Potential role of M. tuberculosis specific IFN-gamma and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis. PLoS One 7:e46041
23. Gourgouillon N, de Lauzanne A, Cottart CH, Curis E, Debord C, Guérin-El Khourouj V et al (2012) TNF-alpha/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study. Pediatr Res 72:370–374
24. Krummel B, Strassburg A, Ernst M, Reiling N, Eker B, Rath H et al (2010) Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing. PLoS One 5:e11670
25. Ruhwald M, Petersen J, Kofoed K, Nakaoka H, Cuevas LE, Lawson L et al (2008) Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 3:e2858
26. Goletti D, Raja A, Ahamed Kabeer BS, Rodrigues C, Sodha A, Butera O et al (2010) IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 61:133–143
27. Suter-Riniker F, Berger A, Mayor D, Bittel P, Iseli P, Bodmer T (2011) Clinical significance of interleukin-2/gamma interferon ratios in Mycobacterium tuberculosis-specific T-cell signatures. Clin Vaccine Immunol 18:1395–1396
28. Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M et al (2011) Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One 6:e17813
29. Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240:1285–1293
30. Winkler S, Necek M, Winkler H, Adegnika AA, Perkmann T, Ramharter M et al (2005) Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa. Microbes Infect 7:1161–1169
31. Lanzavecchia A, Sallusto F (2000) Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290:92–97
32. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L et al (2010) Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 40:2211–2220
33. Pantaleo G, Harari A (2006) Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 6:417–423